
Train is a pioneering AI company founded in 2023 as a spin-out from IRCCS Humanitas Research Hospital. Their mission is to drive innovation in clinical trials and advance personalized medicine using generative AI. Their competitive advantage lies in clinical validation and scientific evidence gained through collaborations with domain experts. Train leverages expertise in Generative AI, Large Language Models (LLMs), and Federated Learning to create tailored solutions for pharmaceutical companies conducting clinical research, and for hospitals and healthcare providers seeking to optimize AI usage and improve clinical quality. They support pharmaceutical companies with studies, synthetic data, and digital twin technology for precision medicine, and healthcare providers in creating AI-driven tools.

Train is a pioneering AI company founded in 2023 as a spin-out from IRCCS Humanitas Research Hospital. Their mission is to drive innovation in clinical trials and advance personalized medicine using generative AI. Their competitive advantage lies in clinical validation and scientific evidence gained through collaborations with domain experts. Train leverages expertise in Generative AI, Large Language Models (LLMs), and Federated Learning to create tailored solutions for pharmaceutical companies conducting clinical research, and for hospitals and healthcare providers seeking to optimize AI usage and improve clinical quality. They support pharmaceutical companies with studies, synthetic data, and digital twin technology for precision medicine, and healthcare providers in creating AI-driven tools.